MRT-92 is a Smoothened ( Smo ) antagonist ( K i =0.7 nM) with anticancer activity. MRT-92 inhibits Hedgehog signaling pathway and rodent cerebellar granule cell proliferation by blocking overlapping binding sites in the transmembrane domain of the Smoothened receptor ( IC 50 =0.4 nM). MRT-92 can be used in the study of cerebellar glioma.
Products | Products > Disease Areas > Cancer | Products > Signaling Pathways > Stem Cell/Wnt | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Stem Cells | Products > Signaling Pathways > Smo | Products > Signaling Pathways > Hedgehog
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.